Trial
NCT04740034
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
—
Condition
Metastatic Castration-resistant Prostate Cancer
Intervention
AMG 340
Why stopped
Sponsor strategic decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-17